Inogen Stock Price and Value Analysis

Should you buy Inogen stock? (NasdaqGS:INGN). Let's see how it does in our automated value investing analysis system.

INGN Free Cash Flow Trend

Free Cash Flow trendline for INGN
Free Cash Flow trendline for Inogen

Based on historical returns, we believe that Inogen can grow its free cash at a rate of about 6%. That's positive!

  • This company is making money at a decent rate.
  • This company has wild ups and downs.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the INGN Numbers

INGN Price
(Inogen stock price per share)
[?] INGN Fair Price
(based on intrinsic value)
[?] INGN Safety Price (based on a variable margin of safety) $10.14
[?] PE Ratio versus Sector 179% higher than other Healthcare stocks
[?] PE Ratio versus Industry 605% higher than other Medical Devices stocks
[?] Cash Yield 6.62%
[?] Free Cash Flow Jitter 39%

Is Inogen Stock on Sale?

We believe that Inogen may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Inogen looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy INGN Stock?

Does Inogen have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.